RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Vernadeth Alarcon to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Vernadeth Alarcon has written about Antiviral Agents.
Vernadeth Alarcon
Connection Strength
0.205
Antiviral Agents
  1. Marikawa Y, Alarcon VB. An active metabolite of the anti-COVID-19 drug molnupiravir impairs mouse preimplantation embryos at clinically relevant concentrations. Reprod Toxicol. 2023 10; 121:108475.
    View in: PubMed
    Score: 0.205
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support